These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21521647)

  • 1. Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.
    Gould RW; Gage HD; Banks ML; Blaylock BL; Czoty PW; Nader MA
    Neuropharmacology; 2011; 61(1-2):245-51. PubMed ID: 21521647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.
    Banks ML; Czoty PW; Gage HD; Bounds MC; Garg PK; Garg S; Nader MA
    Neuropsychopharmacology; 2008 Jan; 33(2):219-25. PubMed ID: 17443127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
    McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
    Schenk S; Hely L; Lake B; Daniela E; Gittings D; Mash DC
    Eur J Neurosci; 2007 Dec; 26(11):3229-36. PubMed ID: 18005064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
    Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
    Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
    Urban NB; Girgis RR; Talbot PS; Kegeles LS; Xu X; Frankle WG; Hart CL; Slifstein M; Abi-Dargham A; Laruelle M
    Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary Results on the Long-Term Effects of Dextromethorphan on MDMA-Mediated Serotonergic Deficiency and Volumetric Changes in Primates Based on 4-[
    Yeh SH; Kuo YY; Huang WS; Chiu CH; Yu TH; Ii LGF; Tsai CJ; Cheng CY; Ma KH
    Front Neurosci; 2022; 16():837194. PubMed ID: 35692422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.
    Szabo Z; McCann UD; Wilson AA; Scheffel U; Owonikoko T; Mathews WB; Ravert HT; Hilton J; Dannals RF; Ricaurte GA
    J Nucl Med; 2002 May; 43(5):678-92. PubMed ID: 11994534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
    Fantegrossi WE; Woolverton WL; Kilbourn M; Sherman P; Yuan J; Hatzidimitriou G; Ricaurte GA; Woods JH; Winger G
    Neuropsychopharmacology; 2004 Jul; 29(7):1270-81. PubMed ID: 15039771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of serotonin transporters by positron emission tomography with [11C]DASB in conscious common marmosets: comparison with rhesus monkeys.
    Yokoyama C; Yamanaka H; Onoe K; Kawasaki A; Nagata H; Shirakami K; Doi H; Onoe H
    Synapse; 2010 Aug; 64(8):594-601. PubMed ID: 20340166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the relative reinforcing strength of (+/-)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine.
    Wang Z; Woolverton WL
    Psychopharmacology (Berl); 2007 Jan; 189(4):483-8. PubMed ID: 17063335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [
    Kim JH; Kim JH; Son YD; Joo YH; Lee SY; Kim HK; Woo MK
    Schizophr Res; 2017 Apr; 182():55-65. PubMed ID: 27760700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextromethorphan moderates reward deficiency associated with central serotonin transporter availability in 3,4-methylenedioxy-methamphetamine-treated animals.
    Chiu CH; Ma KH; Huang EY; Chang HW; Weng SJ; Yu TH; Farn SS; Kuo YY; Huang WS; Cheng CY; Tao PL; Yeh SH
    J Chin Med Assoc; 2024 May; 87(5):538-549. PubMed ID: 38587377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging of dopamine transporters and D2/D3 receptors in female monkeys: effects of chronic cocaine self-administration.
    Allen MI; Duke AN; Nader SH; Adler-Neal A; Solingapuram Sai KK; Reboussin BA; Gage HD; Voll RJ; Mintz A; Goodman MM; Nader MA
    Neuropsychopharmacology; 2023 Sep; 48(10):1436-1445. PubMed ID: 37349473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users.
    Frokjaer VG; Erritzoe D; Holst KK; Madsen KS; Fisher PM; Madsen J; Svarer C; Knudsen GM
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1119-28. PubMed ID: 24524290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4-methylenedioxymethamphetamine users.
    van de Blaak FL; Dumont GJH
    Hum Psychopharmacol; 2022 Jan; 37(1):e2811. PubMed ID: 34506649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats.
    Shih JH; Chiu CH; Ma KH; Huang YS; Shiue CY; Yeh TY; Kao LT; Lin YY; Li IH
    Pharmacol Res; 2019 Apr; 142():283-293. PubMed ID: 30826457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.